Heart transplantation is a valid therapeutic option for anthracycline cardiomyopathy

Transplant Proc. 1995 Apr;27(2):1683.
No abstract available

MeSH terms

  • Actuarial Analysis
  • Adult
  • Azathioprine / therapeutic use
  • Cardiomyopathies / chemically induced
  • Cardiomyopathies / surgery*
  • Cyclosporine / therapeutic use
  • Daunorubicin / adverse effects*
  • Doxorubicin / adverse effects*
  • Female
  • Heart Transplantation* / immunology
  • Heart Transplantation* / mortality
  • Humans
  • Immunosuppression Therapy / methods
  • Male
  • Neoplasms / drug therapy*
  • Prednisolone / therapeutic use
  • Survival Rate

Substances

  • Doxorubicin
  • Cyclosporine
  • Prednisolone
  • Azathioprine
  • Daunorubicin